CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VRTX

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
2mo
VRTXPDUFA
Phase 3

FDA PDUFA Date povetacicept

Povetacicept
Nov 30
Source
00%
Competitive Landscape

1 competitor in Primary Membranous Nephropathy

View Full Landscape
Drug Information

Target Indication

Primary Membranous Nephropathy

Clinical Trial

NCT07204275

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.